Paper36959692
Allogeneic Hematopoietic Stem Cell Transplantation for Primary Myelofibrosis: A 20-year Experience in a Single Center
Cengiz Seval G and 10 others. Balkan Med J, 2023. Cited by 1 paper, by iCite.
Cite this record
ConductScience Library. Allogeneic Hematopoietic Stem Cell Transplantation for Primary Myelofibrosis: A 20-year Experience in a Single Center. Papers, record 36959692. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36959692
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Allogeneic Hematopoietic Stem Cell Transplantation for Primary Myelofibrosis: A 20-year Experience in a Single Center
- PubMed
Topics7
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Primary Myelofibrosis | Major topic |
| Hematopoietic Stem Cell Transplantation | Major topic |
| Graft vs Host Disease | Major topic |
| Humans | |
| Treatment Outcome | |
| Retrospective Studies | |
| Cross-Sectional Studies |
Source PubMed
References38
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 19879949 | Outcome of transplantation for myelofibrosis. | Biol Blood Marrow Transplant | 2010 | https://conductscience.org/library/papers/19879949 | PubMed |
| 2 | 23838352 | Revised response criteria for myelofibrosis: International Working Group-Myeloproliferative Neoplasms Research and Treatment (IWG-MRT) and European LeukemiaNet (ELN) consensus report. | Blood | 2013 | https://conductscience.org/library/papers/23838352 | PubMed |
| 3 | 29808926 | Outcome of patients with Myelofibrosis relapsing after allogeneic stem cell transplant: a retrospective study by the Chronic Malignancies Working Party of EBMT. | Br J Haematol | 2018 | https://conductscience.org/library/papers/29808926 | PubMed |
| 4 | 32286544 | Determinants of survival in myelofibrosis patients undergoing allogeneic hematopoietic cell transplantation. | Leukemia | 2021 | https://conductscience.org/library/papers/32286544 | PubMed |
| 5 | 33108024 | Splenectomy before allogeneic hematopoietic cell transplantation for myelofibrosis: A French nationwide study. | Am J Hematol | 2021 | https://conductscience.org/library/papers/33108024 | PubMed |
| 6 | 20008785 | A dynamic prognostic model to predict survival in primary myelofibrosis: a study by the IWG-MRT (International Working Group for Myeloproliferative Neoplasms Research and Treatment). | Blood | 2010 | https://conductscience.org/library/papers/20008785 | PubMed |
| 7 | 22909192 | Donor lymphocyte infusions and second transplantation as salvage treatment for relapsed myelofibrosis after reduced-intensity allografting. | Br J Haematol | 2012 | https://conductscience.org/library/papers/22909192 | PubMed |
| 8 | 32165328 | Indications for Hematopoietic Cell Transplantation and Immune Effector Cell Therapy: Guidelines from the American Society for Transplantation and Cellular Therapy. | Biol Blood Marrow Transplant | 2020 | https://conductscience.org/library/papers/32165328 | PubMed |
| 9 | 10733489 | Splenectomy in myelofibrosis with myeloid metaplasia: a single-institution experience with 223 patients. | Blood | 2000 | https://conductscience.org/library/papers/10733489 | PubMed |
| 10 | 4153799 | Clinical manifestations of graft-versus-host disease in human recipients of marrow from HL-A-matched sibling donors. | Transplantation | 1974 | https://conductscience.org/library/papers/4153799 | PubMed |
| 11 | 32384540 | Survival following allogeneic transplant in patients with myelofibrosis. | Blood Adv | 2020 | https://conductscience.org/library/papers/32384540 | PubMed |
| 12 | 25529383 | National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. The 2014 Diagnosis and Staging Working Group report. | Biol Blood Marrow Transplant | 2015 | https://conductscience.org/library/papers/25529383 | PubMed |
| 13 | 31284069 | Myeloablative and Reduced-Intensity Conditioned Allogeneic Hematopoietic Stem Cell Transplantation in Myelofibrosis: A Retrospective Study by the Chronic Malignancies Working Party of the European Society for Blood and Marrow Transplantation. | Biol Blood Marrow Transplant | 2019 | https://conductscience.org/library/papers/31284069 | PubMed |
| 14 | 34052505 | Outcomes of Allogeneic Hematopoietic Cell Transplantation in Patients With Myelofibrosis-A Systematic Review and Meta-Analysis. | Transplant Cell Ther | 2021 | https://conductscience.org/library/papers/34052505 | PubMed |
| 15 | 30408564 | Family Mismatched Allogeneic Stem Cell Transplantation for Myelofibrosis: Report from the Chronic Malignancies Working Party of European Society for Blood and Marrow Transplantation. | Biol Blood Marrow Transplant | 2019 | https://conductscience.org/library/papers/30408564 | PubMed |
| 16 | 24862637 | CD34 selected cells for the treatment of poor graft function after allogeneic stem cell transplantation. | Biol Blood Marrow Transplant | 2014 | https://conductscience.org/library/papers/24862637 | PubMed |
| 17 | 21133885 | Allogeneic haematopoietic stem cell transplantation for myelofibrosis: a report of the Société Française de Greffe de Moelle et de Thérapie Cellulaire (SFGM-TC). | Br J Haematol | 2011 | https://conductscience.org/library/papers/21133885 | PubMed |
| 18 | 23573823 | Splenectomy in patients with myeloproliferative neoplasms: efficacy, complications and impact on survival and transformation. | Leuk Lymphoma | 2014 | https://conductscience.org/library/papers/23573823 | PubMed |
| 19 | 30872371 | State-of-the-art review: allogeneic stem cell transplantation for myelofibrosis in 2019. | Haematologica | 2019 | https://conductscience.org/library/papers/30872371 | PubMed |
| 20 | 32297800 | Management of myelofibrosis after ruxolitinib failure. | Leuk Lymphoma | 2020 | https://conductscience.org/library/papers/32297800 | PubMed |
Cited by1
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 1 citation.
| PMID | Title | Journal | Year | In Papers |
|---|---|---|---|---|
| 41815185 | Clinical Outcomes of Allogeneic Stem Cell Transplantation in Myelofibrosis - A Single Center Experience. | Blood Cell Ther | 2026 | https://conductscience.org/library/papers/41815185 |
Source PubMed
Genes2
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| CD34 | 947 | PubTator's text mining | https://conductscience.org/library/genes/947 | NCBI Gene |
| JAK2 | 3717 | PubTator's text mining | https://conductscience.org/library/genes/3717 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/36959692
GET https://conductscience.org/api/papers/v1/36959692/references?page=2